Matthew J. Maletta
Endo Pharmaceuticals Inc.
United States of America
Matthew J. Maletta was appointed Executive Vice President, Chief Legal Officer effective May 4, 2015. He has 20 years of legal experience in the specialty pharmaceutical industry and with private law firms, including extensive experience in M&A, corporate, securities, finance, commercial and employment law. Prior to joining Endo, Mr. Maletta served as Vice President, Associate General Counsel and Corporate Secretary of Allergan, Inc. In this position, he served as an advisor to the CEO and Board of Directors and supervised several large M&A transactions and takeover defense activities, including Allergan’s acquisition of Inamed and Actavis’ acquisition of Allergan. Mr. Maletta first joined Allergan in 2002 as Corporate Counsel and Assistant Secretary and during his tenure, held various roles of increased responsibility. He had a key role negotiating Allergan’s Corporate Integrity Agreement with the Department of Justice, served as the lead commercial attorney for the Allergan medical businesses and served as Interim Head of Human Resources. Prior to joining Allergan, Mr. Maletta was in private practice, focusing on general corporate matters, finance, governance, securities and transactions. He holds a B.A. degree in political science from the University of Minnesota, summa cum laude, and a J.D. degree, cum laude, from the University of Minnesota Law School. From 2012 – 2015, Mr. Maletta served as a member of the Board of Directors of United Cerebral Palsy – Orange County (UCP) and co-chaired UCP’s annual “Life Without Limits” galas in 2012, 2013 and 2015.
Host defense mechanisms,LPS effects on neurotransmitters